Key result
This practical guide outlines the prescription of direct oral anticoagulants, red flags for patients in the emergency department, and advances in the treatment of bleeding complications.
This review provides a practical guide for emergency clinicians on prescribing DOACs, identifying bleeding red flags, and managing bleeding complications.
May guide emergency DOAC prescribing and bleeding care; leaves open prospective validation of red flags and protocols.
The direct oral anticoagulants (DOACs) are the mainstay for stroke prophylaxis in nonvalvular atrial fibrillation and treatment of acute venous thrombosis. They are attractive alternatives to warfarin because of their efficacy, ease of prescription and safety profile. The emergency department has gained expertise in the management of DOAC bleeding complications, but has been slower to adopt prescription decisions. Emergency clinicians are in a unique position to identify patients who are prescribed DOACs and are at high risk of impending bleeding. This is a practical guide for the emergency clinician on how to prescribe DOACs, the red flags for DOAC patients in the emergency department and advances in the treatment of bleeding.
No takes yet. Share an insight, caveat, or question.
Hogg et al. (2016) conducted a review in Nonvalvular atrial fibrillation and acute venous thrombosis. Direct oral anticoagulants (DOACs) was evaluated. This practical guide outlines the prescription of direct oral anticoagulants, red flags for patients in the emergency department, and advances in the treatment of bleeding complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: